Business Context and Reporting Period
This Form 6-K filing by CollPlant Biotechnologies Ltd. covers the month of August 2019, with the report dated August 19, 2019. The registrant is a foreign private issuer based in Rehovot, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance updates rather than financial performance.
Material Changes
The primary material change reported is the appointment of a new board member:
- Board Appointment: On August 15, 2019, the Board of Directors appointed Joseph Zarzewsky as a member, effective immediately.
- Background: Mr. Zarzewsky brings experience in business development, joint ventures in China (SMAD), and investment committees (Harbin Israel Fund). He holds an MA in Commercial Law.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the effective date of Joseph Zarzewsky's board appointment (August 15, 2019).
- Review Mr. Zarzewsky's prior roles, specifically his tenure at Mitrelli Group and his involvement with the Harbin Government.
- Confirm the incorporation of this report into Registration Statements on Form S-8 and Form F-3.